Which of the following conditions is characterized by low prevalence and high incidence?
What is primordial prevention?
If the cut-off point for blood glucose is lowered to detect diabetes (e.g., less than 120 mg/dL), what is the effect on the test's performance characteristics?
James Lind is associated with which of the following?
What is the number of live births per 1,000 women of reproductive age?
What is the most common mode of transmission of the poliovirus?
For a disease of unknown etiology, what is the first step in forming a hypothesis?
All of the following features are true about a cross-sectional study EXCEPT?
On what date did the WHO declare COVID-19 a global pandemic?
Which of the following factors does not affect the Hardy-Weinberg equilibrium?
Explanation: The relationship between incidence and prevalence is defined by the formula: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D)**. ### Why Option A is Correct A **highly fatal disease** has a very short duration because the patient dies shortly after contracting the illness. Even if the **Incidence** (number of new cases) is high, the **Prevalence** (total number of existing cases at a given time) remains low because individuals are rapidly removed from the "pool" of cases due to death. Therefore, short duration (D) leads to low prevalence (P). ### Why Other Options are Incorrect * **B. An easily curable disease:** Similar to fatal diseases, these have a short duration. However, the question asks for a condition characterized by *high incidence*. While curable diseases have low prevalence, they do not inherently imply high incidence unless specified (e.g., common cold). * **C. A highly infectious disease with low mortality:** These typically result in high prevalence. If the disease is not fatal and not immediately cured, patients remain in the population pool for a longer period, increasing prevalence. * **D. A chronic disease:** Chronic conditions (e.g., Diabetes, Hypertension) have a long duration. Even with a low or stable incidence, the prevalence becomes high because cases accumulate over many years. ### NEET-PG High-Yield Pearls * **Prevalence** is a **snapshot** (point) or a **slice** (period); **Incidence** is a **flow** (rate). * **Factors increasing Prevalence:** Prolongation of life without a cure, increase in new cases (incidence), in-migration of cases. * **Factors decreasing Prevalence:** High fatality rate, rapid cure rate, out-migration of cases. * **Rule of Thumb:** If a disease is either **rapidly fatal** or **rapidly cured**, its prevalence will always be low relative to its incidence.
Explanation: **Explanation:** **Primordial prevention** is a relatively modern concept in epidemiology that focuses on preventing the emergence or development of risk factors in population groups where they have not yet appeared. It targets the social, economic, and environmental patterns of living (e.g., discouraging children from starting smoking or promoting physical activity to prevent obesity). Unlike other levels of prevention, it acts on the **"underlying conditions"** rather than the disease process itself. **Analysis of Options:** * **Option C (Correct):** Primordial prevention specifically aims to inhibit the development of risk factors. It is the "prevention of the risk factor" itself. * **Option A (Incorrect):** Early diagnosis and treatment (e.g., screening programs like Pap smears or sputum microscopy) constitute **Secondary Prevention**. * **Option B (Incorrect):** Prevention of the development of disease in a person who *already has* risk factors (e.g., using a condom to prevent HIV or immunization) is **Primary Prevention**. * **Option D (Incorrect):** Rehabilitation and disability limitation for patients with established disease represent **Tertiary Prevention**. **High-Yield NEET-PG Pearls:** * **Target Audience:** Primordial prevention is primarily aimed at **children and adolescents** to establish healthy lifelong habits. * **Mode of Intervention:** Individual and mass education. * **Classic Example:** National policies to discourage tobacco use or promoting a healthy diet to prevent the future epidemic of Coronary Heart Disease (CHD). * **Key Distinction:** If the risk factor is **absent**, it is Primordial. If the risk factor is **present** but the disease is absent, it is Primary.
Explanation: ### Explanation **1. Why Option A is Correct:** In screening, sensitivity and specificity have an **inverse relationship**. When you lower the cut-off point for a continuous variable (like blood glucose), you are "widening the net." By lowering the threshold to <120 mg/dL, you will capture more people who actually have the disease (True Positives), but you will also capture more healthy people as "diseased." * **Concept:** Lowering the cut-off increases the number of **True Positives**, thereby **increasing Sensitivity**. **2. Why Other Options are Incorrect:** * **Option B:** Specificity is the ability of a test to correctly identify those without the disease. By lowering the cut-off, you increase the number of **False Positives** (healthy people labeled as diabetic). Since Specificity = TN / (TN + FP), an increase in False Positives leads to a **decrease in Specificity**. * **Option C:** "Predictive accuracy" usually refers to Predictive Values (PPV/NPV). When the cut-off is lowered, the **Positive Predictive Value (PPV) decreases** because the number of False Positives rises significantly. However, the question specifically asks for the primary effect on performance characteristics; the most direct and certain impact is on Sensitivity. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic:** **L**ower the cut-off = **L**ess Specific, but more Sensitive. * **Screening vs. Diagnostic:** Screening tests require high **Sensitivity** (to not miss cases), while diagnostic tests require high **Specificity** (to confirm the disease). * **The "Trade-off":** On a ROC (Receiver Operating Characteristic) curve, moving the cut-off point to the left/down increases sensitivity at the cost of specificity. * **Prevalence:** Remember that while Sensitivity and Specificity are inherent properties of the test, **Predictive Values** (PPV/NPV) change with the prevalence of the disease in the population.
Explanation: **Explanation:** **James Lind** (1716–1794), a Scottish naval physician, is celebrated as the father of the **first clinical trial** in medical history. In 1747, while serving on the HMS Salisbury, he conducted a controlled experiment on sailors suffering from **Scurvy**. He divided them into groups and provided different dietary supplements, discovering that those given **citrus fruits (lemons and oranges)** recovered rapidly. This established the link between citrus consumption and the prevention/treatment of Scurvy, long before Vitamin C was formally identified. **Analysis of Incorrect Options:** * **A. Multifactorial causation:** This concept, which posits that diseases (especially non-communicable ones) result from multiple interacting factors, is associated with **Pettenkofer** and later epidemiological models, not Lind. * **C. Pox vaccine:** **Edward Jenner** is the pioneer of the smallpox vaccine (1796), utilizing cowpox material to confer immunity. * **D. Germ theory of disease:** This was primarily developed by **Louis Pasteur** and **Robert Koch** in the late 19th century, proving that microorganisms are the cause of infectious diseases. **High-Yield Clinical Pearls for NEET-PG:** * **James Lind:** Conducted the first "Experimental Epidemiology" study (Clinical Trial). * **John Snow:** Known as the "Father of Modern Epidemiology" for his work on Cholera (Golden Square pump). * **William Farr:** Known as the "Father of Vital Statistics." * **Scurvy:** Caused by Vitamin C (Ascorbic acid) deficiency; characterized by defective collagen synthesis, bleeding gums, and petechiae.
Explanation: ### Explanation **Correct Option: D (General Fertility Rate)** The **General Fertility Rate (GFR)** is defined as the number of live births per 1,000 women in the reproductive age group (usually 15–44 or 15–49 years) in a given year. Unlike the Crude Birth Rate, which uses the total population as the denominator, GFR is a more refined measure because it restricts the denominator to the specific segment of the population capable of giving birth. **Why the other options are incorrect:** * **A. Net Reproductive Rate (NRR):** This measures the number of daughters a newborn girl will bear during her lifetime, assuming fixed age-specific fertility and mortality rates. An NRR of 1.0 is the demographic goal for population stabilization. * **B. Total Fertility Rate (TFR):** This represents the average number of children a woman would have if she were to pass through her reproductive years bearing children according to current age-specific fertility rates. It is a hypothetical measure of completed family size. * **C. Gross Reproduction Rate (GRR):** This is similar to TFR but only counts the number of female births. It ignores maternal mortality. **High-Yield Pearls for NEET-PG:** * **Denominator of GFR:** Mid-year female population aged 15–49 years. * **Replacement Level Fertility:** Defined as a TFR of **2.1**. Achieving this leads to NRR = 1. * **Most Sensitive Index of Fertility:** Total Fertility Rate (TFR). * **Best Indicator of Population Growth:** Net Reproductive Rate (NRR). * **Crude Birth Rate (CBR):** The simplest measure of fertility, using the total mid-year population as the denominator.
Explanation: **Explanation:** The poliovirus is an enterovirus belonging to the Picornaviridae family. The **fecal-oral route** is the most common and primary mode of transmission, particularly in areas with poor sanitation and hygiene. After ingestion, the virus multiplies in the Peyer’s patches of the ileum and is excreted in large quantities in the feces for several weeks, facilitating community spread via contaminated water, food, or hands. **Analysis of Options:** * **A. Droplet infection:** While the virus can be found in the nasopharynx during the early stages (incubation period) and can spread via droplets, this is a **minor/secondary** route. It is more common in developed countries with high hygiene standards but is not the "most common" globally. * **C. Blood transfusion:** Poliovirus does not survive well in the bloodstream for transmission via transfusion; viremia is transient and occurs before the onset of clinical symptoms. * **D. Vertical transmission:** There is no documented evidence of the poliovirus crossing the placenta to cause congenital infection. **High-Yield Clinical Pearls for NEET-PG:** * **Reservoir:** Man is the only known reservoir; there are no chronic carriers. * **Infectivity:** Maximum infectivity occurs during the late incubation period and the first week of clinical illness. * **Virus Shedding:** The virus persists in the throat for about 1 week and in the feces for 6–8 weeks. * **Immunity:** Type-specific immunity is lifelong. * **Vaccine Strains:** The Oral Polio Vaccine (OPV) uses the **Sabin** strain (live attenuated), while the Inactivated Polio Vaccine (IPV) uses the **Salk** strain (killed).
Explanation: ### Explanation In epidemiology, the investigation of a disease follows a logical, step-by-step sequence known as the **Epidemiological Cycle**. When dealing with a disease of unknown etiology, the primary objective is to generate a hypothesis, which is always the domain of **Descriptive Epidemiology**. **Why Descriptive Epidemiology is Correct:** Descriptive epidemiology involves the systematic collection and analysis of data regarding **Time, Place, and Person**. By observing who is getting the disease, where it is occurring, and when it is peaking, researchers can identify patterns. These patterns allow for the formulation of a hypothesis regarding the potential source, mode of transmission, or risk factors. You cannot test a hypothesis (Analytical Epidemiology) until you have first formed one (Descriptive Epidemiology). **Analysis of Incorrect Options:** * **A. Cross-sectional study:** While often used to determine prevalence, it is a specific study design. Descriptive epidemiology is the broader, initial phase that encompasses simple observations before a formal cross-sectional study is even designed. * **C. Case-control study:** This is a type of **Analytical Epidemiology**. It is used to *test* a hypothesis by comparing those with the disease to those without. It follows descriptive studies. * **D. Cohort study:** This is also **Analytical Epidemiology**. It is used to confirm the *association* and determine the incidence/relative risk. It is typically the most expensive and time-consuming step, performed only after a hypothesis is well-established. **NEET-PG High-Yield Pearls:** * **Sequence of Investigation:** Descriptive Epidemiology (Hypothesis Formation) → Analytical Epidemiology (Hypothesis Testing) → Experimental Epidemiology (Hypothesis Confirmation). * **Descriptive Epidemiology** answers: Who, Where, and When? * **Analytical Epidemiology** answers: How and Why? * **The "Gold Standard"** for proving a causal relationship is the Randomized Controlled Trial (RCT), but the "Gold Standard" for observational studies is the Cohort Study.
Explanation: ### Explanation **Why Option D is the Correct Answer (The "Except" Statement):** A cross-sectional study is often referred to as a **"Snapshot Study"** because it measures both the exposure and the outcome simultaneously at a single point in time. Because both are measured together, it is impossible to determine whether the exposure preceded the outcome. This lack of **temporality** (the first criterion of Bradford Hill’s criteria for causation) means that a cross-sectional study can show an **association** but cannot establish a definitive **cause-and-effect relationship**. **Analysis of Incorrect Options:** * **Option A:** This is a defining feature. It examines the prevalence of a condition in a population at one specific point in time (like a still photograph). * **Option B:** Unlike cohort studies, there is no forward-looking component. Once the data is collected from the participants, the study is complete; hence, follow-up is not required. * **Option C:** These studies are ideal for chronic conditions (e.g., Diabetes, Hypertension) because they measure **prevalence**. They are less useful for acute or rare diseases, as the "snapshot" might miss short-lived cases. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence Study:** Cross-sectional study is the best design to calculate the prevalence of a disease. * **Hypothesis Generation:** It is used to generate hypotheses, whereas analytical studies (Case-control/Cohort) are used to test them. * **Sequence of Strength:** Cross-sectional < Case-Control < Cohort < Randomized Controlled Trial (RCT). * **Ecological Fallacy:** Often associated with ecological studies, but remember that cross-sectional studies focus on individuals, not populations.
Explanation: **Explanation:** The World Health Organization (WHO) officially declared COVID-19 a **Global Pandemic** on **11th March 2020**. This declaration was made by Director-General Dr. Tedros Adhanom Ghebreyesus due to the alarming levels of spread, severity, and inaction across multiple countries. In epidemiology, a pandemic is defined as the worldwide spread of a new disease, crossing international boundaries and affecting a large number of people. **Analysis of Options:** * **11th Feb 2020 (Option A):** This is the date the WHO officially named the disease **"COVID-19"** (Coronavirus Disease 2019). On the same day, the ICTV named the virus **SARS-CoV-2**. * **30th Jan 2020 (Option C):** This is a high-yield date marking when the WHO declared the outbreak a **Public Health Emergency of International Concern (PHEIC)**. This is also the date the first laboratory-confirmed case was reported in India (Kerala). * **15th March 2020 (Option D):** This date holds no specific global significance regarding WHO declarations, though many countries began implementing national lockdowns around this period. **High-Yield Clinical Pearls for NEET-PG:** * **First Case (Global):** Reported in Wuhan, China, in December 2019. * **First Case (India):** 30th January 2020 (Thrissur, Kerala). * **Janata Curfew (India):** 22nd March 2020. * **Epidemiological Triad for COVID-19:** Agent (SARS-CoV-2), Host (Humans, especially elderly/comorbid), Environment (Overcrowding, poor ventilation). * **Incubation Period:** Average 5–6 days (Range: 2–14 days).
Explanation: ### Explanation The **Hardy-Weinberg Principle** is a fundamental concept in population genetics which states that allele and genotype frequencies in a population will remain constant (in equilibrium) from generation to generation in the absence of evolutionary influences. #### Why "Random Mating" is the Correct Answer For a population to remain in equilibrium, **random mating (panmixia)** is a **requirement**, not a disruptive factor. In random mating, every individual has an equal chance of mating with any other individual of the opposite sex. This ensures that genes are shuffled without changing the overall frequency. Therefore, random mating **maintains** the equilibrium rather than affecting or disrupting it. #### Analysis of Incorrect Options (Factors that DO affect equilibrium) * **Small population size (Genetic Drift):** In small populations, chance events can cause allele frequencies to fluctuate unpredictably. Large population size is required to minimize this "sampling error." * **Mutations:** The sudden change in DNA sequences introduces new alleles into the gene pool, thereby altering existing frequencies. * **Gene flow (Migration):** The movement of individuals (and their genes) into or out of a population changes the local allelic makeup. * **Natural Selection:** If certain phenotypes have a survival advantage, those alleles will increase in frequency, breaking the equilibrium. #### NEET-PG High-Yield Pearls * **The Formula:** $p^2 + 2pq + q^2 = 1$ (where $p$ and $q$ are the frequencies of dominant and recessive alleles). * **Assumptions for Equilibrium:** Large population, Random mating, No mutation, No migration, and No selection. * **Clinical Application:** This principle is used in public health to calculate the **carrier frequency** of autosomal recessive diseases (e.g., Cystic Fibrosis, Phenylketonuria) in a population when only the disease prevalence ($q^2$) is known.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free